Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays that recruitment is closed with a 'No longer looking for participants' notice. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and a minor formatting change was made to the Interventions label (Intervention / Treatment → Intervention/Treatment) along with a revision version update from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check19 days agoChange DetectedThe page version was updated from v3.5.4 to v3.5.5. This appears to be a minor maintenance update to the page.SummaryDifference0.0%

- Check34 days agoChange DetectedA new reference to a 2025 publication by Cummings et al. evaluating cognitive, functional, and behavioral effects observed in EMERGE (the aducanumab Phase 3 trial) was added to the Publications section.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, signaling a minor update to the page.SummaryDifference0.0%

- Check55 days agoChange DetectedThe entry for Malmö, Sweden, 20502 replaces the earlier Malmo, Sweden, 20502 in the Contacts and Locations section. This corrects the city name spelling and adds the proper diacritic.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page’s displayed site/interface revision number was updated from v3.5.0 to v3.5.3, reflecting a change to the platform version rather than the study record content.SummaryDifference0.0%

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.